PET-CT in Clinical Adult Oncology: III. Gastrointestinal Malignancies
PET-CT is an advanced imaging modality with many oncologic applications, including staging, assessment of response to therapy, restaging and longitudinal surveillance for recurrence. The goal of this series of six review articles is to provide practical information to providers and imaging professio...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/11/2668 |
_version_ | 1797493938812092416 |
---|---|
author | Bhasker R. Koppula Gabriel C. Fine Ahmed Ebada Salem Matthew F. Covington Richard H. Wiggins John M. Hoffman Kathryn A. Morton |
author_facet | Bhasker R. Koppula Gabriel C. Fine Ahmed Ebada Salem Matthew F. Covington Richard H. Wiggins John M. Hoffman Kathryn A. Morton |
author_sort | Bhasker R. Koppula |
collection | DOAJ |
description | PET-CT is an advanced imaging modality with many oncologic applications, including staging, assessment of response to therapy, restaging and longitudinal surveillance for recurrence. The goal of this series of six review articles is to provide practical information to providers and imaging professionals regarding the best use of PET-CT for specific oncologic indications, and the potential pitfalls and nuances that characterize these applications. In the third of these review articles, key tumor-specific clinical information and representative PET-CT images are provided to outline the role that PET-CT plays in the management of patients with gastrointestinal malignancies. The focus is on the use of <sup>18</sup>F fluorodeoxyglucose (FDG), rather than on research radiopharmaceuticals under development. Many different types of gastrointestinal tumors exist, both pediatric and adult. A discussion of the role of FDG PET-CT for all of these is beyond the scope of this review. Rather, this article focuses on the most common adult gastrointestinal malignancies that may be encountered in clinical practice. The information provided here will provide information outlining the appropriate role of PET-CT in the clinical management of patients with gastrointestinal malignancies for healthcare professionals caring for adult cancer patients. It also addresses the nuances and provides interpretive guidance related to PET-CT for imaging providers, including radiologists, nuclear medicine physicians and their trainees. |
first_indexed | 2024-03-10T01:27:10Z |
format | Article |
id | doaj.art-c8d994743afb4ca681da803c6aa2fac4 |
institution | Directory Open Access Journal |
issn | 2072-6694 |
language | English |
last_indexed | 2024-03-10T01:27:10Z |
publishDate | 2022-05-01 |
publisher | MDPI AG |
record_format | Article |
series | Cancers |
spelling | doaj.art-c8d994743afb4ca681da803c6aa2fac42023-11-23T13:49:07ZengMDPI AGCancers2072-66942022-05-011411266810.3390/cancers14112668PET-CT in Clinical Adult Oncology: III. Gastrointestinal MalignanciesBhasker R. Koppula0Gabriel C. Fine1Ahmed Ebada Salem2Matthew F. Covington3Richard H. Wiggins4John M. Hoffman5Kathryn A. Morton6Department of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT 84132, USADepartment of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT 84132, USADepartment of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT 84132, USADepartment of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT 84132, USADepartment of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT 84132, USADepartment of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT 84132, USADepartment of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT 84132, USAPET-CT is an advanced imaging modality with many oncologic applications, including staging, assessment of response to therapy, restaging and longitudinal surveillance for recurrence. The goal of this series of six review articles is to provide practical information to providers and imaging professionals regarding the best use of PET-CT for specific oncologic indications, and the potential pitfalls and nuances that characterize these applications. In the third of these review articles, key tumor-specific clinical information and representative PET-CT images are provided to outline the role that PET-CT plays in the management of patients with gastrointestinal malignancies. The focus is on the use of <sup>18</sup>F fluorodeoxyglucose (FDG), rather than on research radiopharmaceuticals under development. Many different types of gastrointestinal tumors exist, both pediatric and adult. A discussion of the role of FDG PET-CT for all of these is beyond the scope of this review. Rather, this article focuses on the most common adult gastrointestinal malignancies that may be encountered in clinical practice. The information provided here will provide information outlining the appropriate role of PET-CT in the clinical management of patients with gastrointestinal malignancies for healthcare professionals caring for adult cancer patients. It also addresses the nuances and provides interpretive guidance related to PET-CT for imaging providers, including radiologists, nuclear medicine physicians and their trainees.https://www.mdpi.com/2072-6694/14/11/2668PETFDGesophageal cancergastric cancerhepatobiliary carcinomasmall-bowel carcinoma |
spellingShingle | Bhasker R. Koppula Gabriel C. Fine Ahmed Ebada Salem Matthew F. Covington Richard H. Wiggins John M. Hoffman Kathryn A. Morton PET-CT in Clinical Adult Oncology: III. Gastrointestinal Malignancies Cancers PET FDG esophageal cancer gastric cancer hepatobiliary carcinoma small-bowel carcinoma |
title | PET-CT in Clinical Adult Oncology: III. Gastrointestinal Malignancies |
title_full | PET-CT in Clinical Adult Oncology: III. Gastrointestinal Malignancies |
title_fullStr | PET-CT in Clinical Adult Oncology: III. Gastrointestinal Malignancies |
title_full_unstemmed | PET-CT in Clinical Adult Oncology: III. Gastrointestinal Malignancies |
title_short | PET-CT in Clinical Adult Oncology: III. Gastrointestinal Malignancies |
title_sort | pet ct in clinical adult oncology iii gastrointestinal malignancies |
topic | PET FDG esophageal cancer gastric cancer hepatobiliary carcinoma small-bowel carcinoma |
url | https://www.mdpi.com/2072-6694/14/11/2668 |
work_keys_str_mv | AT bhaskerrkoppula petctinclinicaladultoncologyiiigastrointestinalmalignancies AT gabrielcfine petctinclinicaladultoncologyiiigastrointestinalmalignancies AT ahmedebadasalem petctinclinicaladultoncologyiiigastrointestinalmalignancies AT matthewfcovington petctinclinicaladultoncologyiiigastrointestinalmalignancies AT richardhwiggins petctinclinicaladultoncologyiiigastrointestinalmalignancies AT johnmhoffman petctinclinicaladultoncologyiiigastrointestinalmalignancies AT kathrynamorton petctinclinicaladultoncologyiiigastrointestinalmalignancies |